Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXHL2101236	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2021-11-09	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2101237	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2021-11-09	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2400105	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2024-05-10	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2400106	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2024-05-11	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2500072	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2025-04-09	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2500073	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2025-04-09	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view
JXHL2500132	BI 690517片	BI-690517	Tablet	Chemical Drugs(1)	Import Drug Application	2025-06-11	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH	view